SCHEMBL24087880

SCHEMBL24087880

N#Cc1c(Cc2ccccc2)cc(=O)[nH]c1SCc1cc(F)c(O)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSD11B1 P28845 7/20 0.41
▸ GAA P10253 1/20 0.41
▸ LMNA P02545 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ TSHR P16473 3/20 0.38
▸ GFER P55789 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ HSD11B2 P80365 1/20 0.37
▸ CTSB P07858 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ ACMSD Q8TDX5 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847291 0.89 ALDH1A1 (0.44) ALDH1A1HPGDKMT2AHSD11B1GAA
SCHEMBL24087879 0.85 ALDH1A1 (0.35) ALDH1A1HPGDKMT2AHSD11B1GAA
SCHEMBL20340101 0.81 ACMSD (0.57) ALDH1A1HPGDKMT2AACMSD
SCHEMBL23849883 0.81 ACMSD (0.48) ALDH1A1HPGDKMT2AHSD11B1GAA
SCHEMBL26847205 0.81 KMT2A (0.43) ALDH1A1HPGDKMT2AHSD11B1GAA
SCHEMBL20340210 0.80 KDM4E (0.58) ALDH1A1HPGDKMT2AGAALMNA
SCHEMBL24087949 0.78 ALDH1A1 (0.44) ALDH1A1HPGDKMT2AHSD11B1GAA
SCHEMBL24088145 0.78 KDM4E (0.62) ALDH1A1HPGDKMT2AGAALMNA
SCHEMBL24087956 0.77 KDM4E (0.46) ALDH1A1HPGDKMT2AGAAALOX15
SCHEMBL26847290 0.77 HSD11B1 (0.40) ALDH1A1HPGDKMT2AHSD11B1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ALDH1A1 171/4885HPGD 59/4885KMT2A 1353/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ALDH1A1 171/4885HPGD 59/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback